Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 315

1.

Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.

Vrieze A, Out C, Fuentes S, Jonker L, Reuling I, Kootte RS, van Nood E, Holleman F, Knaapen M, Romijn JA, Soeters MR, Blaak EE, Dallinga-Thie GM, Reijnders D, Ackermans MT, Serlie MJ, Knop FK, Holst JJ, van der Ley C, Kema IP, Zoetendal EG, de Vos WM, Hoekstra JB, Stroes ES, Groen AK, Nieuwdorp M.

J Hepatol. 2014 Apr;60(4):824-31. doi: 10.1016/j.jhep.2013.11.034. Epub 2013 Dec 6.

PMID:
24316517
2.

The effects of amoxicillin and vancomycin on parameters reflecting cholesterol metabolism.

Baumgartner S, Reijnders D, Konings MCJM, Groen AK, Lütjohann D, Goossens GH, Blaak EE, Plat J.

Chem Phys Lipids. 2017 Oct;207(Pt B):239-245. doi: 10.1016/j.chemphyslip.2017.06.006. Epub 2017 Jun 21.

PMID:
28647339
3.

Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity.

Murphy EF, Cotter PD, Hogan A, O'Sullivan O, Joyce A, Fouhy F, Clarke SF, Marques TM, O'Toole PW, Stanton C, Quigley EM, Daly C, Ross PR, O'Doherty RM, Shanahan F.

Gut. 2013 Feb;62(2):220-6. doi: 10.1136/gutjnl-2011-300705. Epub 2012 Feb 16. Erratum in: Gut. 2013 Feb;62(2):226.

PMID:
22345653
4.

Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial.

Reijnders D, Goossens GH, Hermes GD, Neis EP, van der Beek CM, Most J, Holst JJ, Lenaerts K, Kootte RS, Nieuwdorp M, Groen AK, Olde Damink SW, Boekschoten MV, Smidt H, Zoetendal EG, Dejong CH, Blaak EE.

Cell Metab. 2016 Jul 12;24(1):63-74. doi: 10.1016/j.cmet.2016.06.016.

5.

Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection.

Weingarden AR, Chen C, Bobr A, Yao D, Lu Y, Nelson VM, Sadowsky MJ, Khoruts A.

Am J Physiol Gastrointest Liver Physiol. 2014 Feb 15;306(4):G310-9. doi: 10.1152/ajpgi.00282.2013. Epub 2013 Nov 27.

6.

[Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].

Halmos T, Suba I.

Orv Hetil. 2016 Jan 3;157(1):13-22. doi: 10.1556/650.2015.30296. Review. Hungarian.

PMID:
26708682
7.

Gut microbiota composition modifies fecal metabolic profiles in mice.

Zhao Y, Wu J, Li JV, Zhou NY, Tang H, Wang Y.

J Proteome Res. 2013 Jun 7;12(6):2987-99. doi: 10.1021/pr400263n. Epub 2013 May 10.

PMID:
23631562
8.

A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome.

Xiao S, Fei N, Pang X, Shen J, Wang L, Zhang B, Zhang M, Zhang X, Zhang C, Li M, Sun L, Xue Z, Wang J, Feng J, Yan F, Zhao N, Liu J, Long W, Zhao L.

FEMS Microbiol Ecol. 2014 Feb;87(2):357-67. doi: 10.1111/1574-6941.12228. Epub 2013 Oct 21.

9.

Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.

Han JL, Lin HL.

World J Gastroenterol. 2014 Dec 21;20(47):17737-45. doi: 10.3748/wjg.v20.i47.17737. Review.

10.

Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals.

Canfora EE, van der Beek CM, Hermes GDA, Goossens GH, Jocken JWE, Holst JJ, van Eijk HM, Venema K, Smidt H, Zoetendal EG, Dejong CHC, Lenaerts K, Blaak EE.

Gastroenterology. 2017 Jul;153(1):87-97.e3. doi: 10.1053/j.gastro.2017.03.051. Epub 2017 Apr 8.

PMID:
28396144
11.

Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity.

Hwang I, Park YJ, Kim YR, Kim YN, Ka S, Lee HY, Seong JK, Seok YJ, Kim JB.

FASEB J. 2015 Jun;29(6):2397-411. doi: 10.1096/fj.14-265983. Epub 2015 Feb 20.

12.

Laxative treatment with polyethylene glycol decreases microbial primary bile salt dehydroxylation and lipid metabolism in the intestine of rats.

van der Wulp MY, Derrien M, Stellaard F, Wolters H, Kleerebezem M, Dekker J, Rings EH, Groen AK, Verkade HJ.

Am J Physiol Gastrointest Liver Physiol. 2013 Oct 1;305(7):G474-82. doi: 10.1152/ajpgi.00375.2012. Epub 2013 Jul 18.

PMID:
23868407
13.

Dietary modulation of the gut microbiota--a randomised controlled trial in obese postmenopausal women.

Brahe LK, Le Chatelier E, Prifti E, Pons N, Kennedy S, Blædel T, Håkansson J, Dalsgaard TK, Hansen T, Pedersen O, Astrup A, Ehrlich SD, Larsen LH.

Br J Nutr. 2015 Aug 14;114(3):406-17. doi: 10.1017/S0007114515001786. Epub 2015 Jul 2.

14.

Human intestinal microbiota composition is associated with local and systemic inflammation in obesity.

Verdam FJ, Fuentes S, de Jonge C, Zoetendal EG, Erbil R, Greve JW, Buurman WA, de Vos WM, Rensen SS.

Obesity (Silver Spring). 2013 Dec;21(12):E607-15. doi: 10.1002/oby.20466. Epub 2013 Jun 22.

15.

Effect of various antibiotics on modulation of intestinal microbiota and bile acid profile in mice.

Zhang Y, Limaye PB, Renaud HJ, Klaassen CD.

Toxicol Appl Pharmacol. 2014 Jun 1;277(2):138-45. doi: 10.1016/j.taap.2014.03.009. Epub 2014 Mar 20.

16.

Bile acid is a host factor that regulates the composition of the cecal microbiota in rats.

Islam KB, Fukiya S, Hagio M, Fujii N, Ishizuka S, Ooka T, Ogura Y, Hayashi T, Yokota A.

Gastroenterology. 2011 Nov;141(5):1773-81. doi: 10.1053/j.gastro.2011.07.046. Epub 2011 Aug 10.

PMID:
21839040
17.

Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism.

Mikkelsen KH, Frost M, Bahl MI, Licht TR, Jensen US, Rosenberg J, Pedersen O, Hansen T, Rehfeld JF, Holst JJ, Vilsbøll T, Knop FK.

PLoS One. 2015 Nov 12;10(11):e0142352. doi: 10.1371/journal.pone.0142352. eCollection 2015.

18.

Effects of long-term ingestion of difructose anhydride III (DFA III) on intestinal bacteria and bile acid metabolism in humans.

Minamida K, Asakawa C, Sujaya IN, Kaneko M, Abe A, Sone T, Hara H, Asano K, Tomita F.

J Biosci Bioeng. 2006 Feb;101(2):149-56.

PMID:
16569611
19.

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.

Vrieze A, Van Nood E, Holleman F, Salojärvi J, Kootte RS, Bartelsman JF, Dallinga-Thie GM, Ackermans MT, Serlie MJ, Oozeer R, Derrien M, Druesne A, Van Hylckama Vlieg JE, Bloks VW, Groen AK, Heilig HG, Zoetendal EG, Stroes ES, de Vos WM, Hoekstra JB, Nieuwdorp M.

Gastroenterology. 2012 Oct;143(4):913-6.e7. doi: 10.1053/j.gastro.2012.06.031. Epub 2012 Jun 20. Erratum in: Gastroenterology. 2013 Jan;144(1):250.

PMID:
22728514
20.

Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse.

Yap IK, Li JV, Saric J, Martin FP, Davies H, Wang Y, Wilson ID, Nicholson JK, Utzinger J, Marchesi JR, Holmes E.

J Proteome Res. 2008 Sep;7(9):3718-28. doi: 10.1021/pr700864x. Epub 2008 Aug 13.

PMID:
18698804

Supplemental Content

Support Center